Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000440956 | SCV000520630 | benign | not specified | 2016-02-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000676780 | SCV001119435 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000676780 | SCV002545652 | benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | CYC1: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV000676780 | SCV005269759 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676780 | SCV000802582 | likely benign | not provided | 2016-03-09 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003912667 | SCV004729370 | benign | CYC1-related disorder | 2019-03-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |